By Dr. Steffen Rabe on Dienstag, 17. Mai 2022
Category: Uncategorized

FDA lässt BioNTech-Booster für Kleinkinder zu

Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years | FDA

U.S. FDA clears Pfizer's COVID booster shot for young children | Reuters